Glucocorticoids suppress growth in neonatal cardiomyocytes Co-expressing AT2 and AT1 angiotensin receptors

Neonatology

Volumn 97, Issue 3, 2010, Pages 257-265

  Porrello, Enzo R ^a   Meeker, William F ^a   Thomas, Walter G ^b   Widdop, Robert E ^c   Delbridge, Lea M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; AT1 receptor; AT2 receptor; Cardiac hypertrophy; Cell culture; Corticosterone; Dexamethasone; Glucocorticoids; Neonatal rat

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CELL PROTEIN; CORTICOSTERONE; DEXAMETHASONE; PHENYLEPHRINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CELLS, CULTURED; CORTICOSTERONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ANTAGONISM; GENE EXPRESSION; GLUCOCORTICOIDS; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; TRANSDUCTION, GENETIC;

RATTUS;

EID: 70350527091     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000253757     Document Type: Article

References (46)

1. Phillips ID, Simonetta G, Owens JA, Robinson JS, Clarke IJ, McMillen IC: Placental restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus during late gestation. Pediatr Res 1996; 40: 861-866.
2. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP: Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2,205 pregnancies. Obstet Gynecol 2003; 102: 739-752.
3. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989; 320: 1505-1510.
4. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W: Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992; 120: 286-291.
5. Klopfenstein HS, Rudolph AM: Postnatal changes in the circulation and responses to volume loading in sheep. Circ Res 1978; 42: 839-845.
6. Clubb FJ Jr, Bishop SP: Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab Invest 1984; 50: 571-577.
7. Li F, Wang X, Capasso JM, Gerdes AM: Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 1996; 28: 1737-1746.
8. Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, Wong J: Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res 2001; 89: 623-629.
9. Giraud GD, Louey S, Jonker S, Schultz J, Thornburg KL: Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology 2006; 147: 3643-3649.
10. Le Cras TD, Markham NE, Morris KG, Ahrens CR, McMurtry IF, Abman SH: Neonatal dexamethasone treatment increases the risk for pulmonary hypertension in adult rats. Am J Physiol 2000; 278:L822-L829.
11. Lumbers ER, Boyce AC, Joulianos G, Kumarasamy V, Barner E, Segar JL, Burrell JH: Effects of cortisol on cardiac myocytes and on expression of cardiac genes in fetal sheep. Am J Physiol 2005; 288:R567-R574.
12. De Vries WB, van Der Leij FR, Bakker JM, Kamphuis PJ, van Oosterhout MF, Schipper ME, Smid GB, Bartelds B, van Bel F: Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr Res 2002; 52: 900-906.
13. Rudolph AM, Roman C, Gournay V: Perinatal myocardial DNA and protein changes in the lamb: effect of cortisol in the fetus. Pediatr Res 1999; 46: 141-146.
14. Slotkin TA, Seidler FJ, Kavlock RJ, Bartolome JV: Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. Teratology 1991; 43: 301-306.
15. Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, Peuchmaur M, Tronche F, Farman N, Escoubet B, Benitah JP, Jaisser F: Conditional glucocorticoid receptor expression in the heart induces atrioventricular block. FASEB J 2007; 21: 3133-3141.
16. Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE: Cross talk between corticosteroids and α-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovasc Res 2006; 70: 555-565.
17. Sato A, Sheppard KE, Fullerton MJ, FunDer JW: cAMP modulates glucocorticoid-induced protein accumulation and glucocorticoid receptor in cardiomyocytes. Am J Physiol 1996; 271:E827-E833.
18. Barreto-Chaves ML, Aneas I, Krieger JE: Glucocorticoid regulation of angiotensinconverting enzyme in primary culture of adult cardiac fibroblasts. Am J Physiol 2001; 280:R25-R32.
19. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M: Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994; 93: 1592-1601.
20. Bastien NR, Ciuffo GM, Saavedra JM, Lambert C: Angiotensin II receptor expression in the conduction system and arterial duct of neonatal and adult rat hearts. Regul Pept 1996; 63: 9-16.
21. Hunt RA, Ciuffo GM, Saavedra JM, Tucker DC: Quantification and localisation of angiotensin II receptors and angiotensin converting enzyme in the developing rat heart. Cardiovasc Res 1995; 29: 834-840.
22. Porrello ER, Delbridge LMD, Thomas WG: The angiotensin II type 2 (AT 2 ) receptor: an enigmatic seven transmembrane receptor. Front Biosci 2009; 14: 958-972.
23. D'Amore A, Black MJ, Thomas WG: The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptormediated hypertrophy. Hypertension 2005; 46: 1347-1354.
24. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, Hannan RD: Adenoviral- directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 2002; 90: 135-142.
25. MacLellan WR, SchneiDer MD: Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 2000; 62: 289-319.
26. Suzuki J, Matsubara H, Urakami M, Inada M: Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993; 73: 439-447.
27. Wang ZQ, Moore AF, Ozono R, Siragy HM, Carey RM: Immunolocalization of subtype 2 angiotensin II (AT 2 ) receptor protein in rat heart. Hypertension 1998; 32: 78-83.
28. Fryer HJ, Davis GE, Manthorpe M, Varon S: Lowry protein assay using an automatic microtiter plate spectrophotometer. Anal Biochem 1986; 153: 262-266.
29. Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, Miyata T: Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray. Cardiovasc Drugs Ther 2003; 17: 303-310.
30. Gardner DG, Wu JP, LaPointe MC, Hedges BK, Deschepper CF: Expression of the gene for the atrial natriuretic peptide in cardiac myocytes in vitro. Cardiovasc Drugs Ther 1988; 2: 479-486.
31. 2+current. J Mol Cell Cardiol 1999; 31: 1551-1558.
32. Griffin EE, Wildenthal K: Regulation of cardiac protein balance by hydrocortisone: interaction with insulin. Am J Physiol 1978; 234:E306-E313.
33. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U: The angiotensin II AT 2 receptor is an AT 1 receptor antagonist. J Biol Chem 2001; 276: 39721-39726.
34. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T: Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001; 104: 346-351.
35. Senbonmatsu T, Ichihara S, Price E Jr, Gaffney FA, Inagami T: Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000; 106:R25-R29.
36. Yan X, Price RL, Nakayama M, Ito K, Schuldt AJ, Manning WJ, Sanbe A, Borg TK, Robbins J, Lorell BH: Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am J Physiol 2003; 285:H2179-H2187.
37. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E Jr, Roberts RL, ImboDen H, Fitzgerald TG, Gaffney FA, Inagami T: A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003; 22: 6471-6482.
38. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S: The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 2000; 19: 2537-2548.
39. Miura S, Karnik SS: Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition. J Hypertens 1999; 17: 397-404.
40. Miura S, Karnik SS: Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 2000; 19: 4026-4035.
41. Falcon BL, Veerasingham SJ, Sumners C, Raizada MK: Angiotensin II type 2 receptormediated gene expression profiling in human coronary artery endothelial cells. Hypertension 2005; 45: 692-697.
42. De Vries WB, Bal MP, Homoet-van Der Kraak P, Kamphuis PJ, van Der Leij FR, Baan J, Steendijk P, de Weger RA, van Bel F, van Oosterhout MF: Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment. Basic Res Cardiol 2006; 101: 36-42.
43. Segar JL, Lumbers ER, Nuyt AM, Smith OJ, Robillard JE: Effect of antenatal glucocorticoids on sympathetic nerve activity at birth in preterm sheep. Am J Physiol 1998; 274: R160-R167.
44. Porrello ER, Bell JR, Schertzer JD, Curl CL, McMullen JR, Mellor KM, Ritchie RH, Lynch GS, Harrap SB, Thomas WG, Delbridge LM: Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction. Am J Physiol 2009; 296:R672-R680.
45. Bal MP, de Vries WB, Steendijk P, Homoetvan Der Kraak P, van Der Leij FR, Baan J, van Oosterhout MF, van Bel F: Histopathological changes of the heart after neonatal dexamethasone treatment: studies in 4-, 8-, and 50-week-old rats. Pediatr Res 2009; 66: 74-79.
46. Bal MP, de Vries WB, van Oosterhout MF, Baan J, van Der Wall EE, van Bel F, Steendijk P: Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressurevolume loops in rats. J Appl Physiol 2008; 104: 446-450.